Effect of diphenylhydantoin and phenobarbital on overt and latent tetany.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001769:Blood; D002118:Calcium; D002648:Child; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology; D007011:Hypoparathyroidism / Q000150:complications; D008274:Magnesium; D008875:Middle Aged; D010634:Phenobarbital / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use*; D010758:Phosphorus; D012640:Seizures / Q000188:drug therapy*; D013182:Sprue, Tropical / Q000150:complications; D013746:Tetany / Q000175:diagnosis* / Q000188:drug therapy*
D010758:Phosphorus; D010672:Phenytoin; D008274:Magnesium; D002118:Calcium; D010634:Phenobarbital